<DOC>
	<DOCNO>NCT01621451</DOCNO>
	<brief_summary>Aspirin and/or clopidogrel user increase due increase prevalence cardiovascular cerebrovascular disease age society Korea . Also , patient endoscopic mucosal resection ( EMR ) endoscopic submucosal dissection ( ESD ) early gastric cancer gastric premalignant lesion include adenoma dysplasia increase among aspirin and/or clopidogrel user . Practically , aspirin clopidogrel recommend stop 5~14 day EMR ESD bleed risk procedure . And recommend restart aspirin and/or clopidogrel soon possible immediate bleeding procedure occur consideration thromboembolic risk . However , early restarting aspirin and/or clopidogrel raise risk delay bleed risk complication associate delayed ulcer heal . Although important determine time restart aspirin and/or clopidogrel consideration complication post-EMR/ESD ulcer thromboembolic risk , definite guideline time restart aspirin and/or clopidogrel . This study aim determine timing restart aspirin and/or clopidogrel patient EMR ESD among aspirin and/or clopidogrel user . The investigator plan compare delay bleed rate ulcer heal rate patient post-EMR/ESD ulcer take proton pump inhibitor ( pantoprazole 40 mg per day ) patient restart aspirin and/or clopidogrel within 3~4 day procedure patient restart aspirin and/or clopidogrel 2 week procedure 4 week . The primary endpoint delay ulcer bleed rate 4 week EMR/ESD . The secondary end point ulcer heal rate within 4 week .</brief_summary>
	<brief_title>Does Early Re-administration Aspirin/Clopidogrel Increase Risk Bleeding From Artificial Ulcer After EMR ESD ?</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Patients take aspirin and/or clopidogrel cardiovascular and/or cerebrovascular disease find early gastric cancer premalignant lesion include adenoma dysplasia upper endoscopy . Patients know coagulopathy abnormal coagulation test ( prothrombin time , partial thromboplastin time platelet count ) Patients receive antithrombotic , anticoagulant drug Patients need continuation nonsteroidal antiinflammatory drug , cyclooxygenase2 ( COX2 ) inhibitor , steroid EMR/ESD Patient recent percutaneous coronary intervention ( placement drug elute coronary artery stent within 12 month , bare metal coronary artery stent within 1 month ) Patient 's age &gt; 80 yearold &lt; 18 yearold Patient severe cardiovascular , pulmonary , hepatic , renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>